Nacimbio JSC, a pharmaceutical subsidiary of Rostec Corporation, signed four new contracts with the Russian Ministry of Health for 2018 supplies of blood-derived products under the Seven Nosologies program.
The contracts totaling more than 1.7 billion rubles provide for supplies of medicines in the amount of more than 222 million IU, including blood clotting factors VIII, IX; blood clotting factor VIII + von Willebrand factor. Earlier, the Ministry purchased from this pharmaceutical holding company nearly 20 million units of Anti-Inhibitor Coagulant Complex for more than 1 billion rubles.
This year, for the first time, Nacimbio is using its innovative technology and logistical solutions for transportation of drugs through the cold chain system. This allows to minimize the possibility of breaching the conditions established for storage and transportation of temperature-dependent complex cargo.
In particular, the company uses latest generation of thermal containers that can continuously maintain the necessary temperature regime for up to seven days, or twice as long as most solutions available in the market. New solutions are already used by the holding company to supply Anti-Inhibitor Coagulant Complex, which was delivered to recipients of the Ministry of Health on May 10, 2018, or 10 days ahead of schedule.
The company is also introducing a new modern system for monitoring the movement of cargo and temperature in containers, which uses a set of sensors to provide online information on the status and location of goods. This system will allow to improve the efficiency of supplies, quickly respond to potential deviations, and provide customers with up-to-the-minute information on movement of cargo with medicinal products.